Lingua: Inglese
Editore: Springer-Verlag Berlin and Heidelberg GmbH & Co. K -, 2002
ISBN 10: 3540432299 ISBN 13: 9783540432296
Da: Bahamut Media, Reading, Regno Unito
EUR 5,03
Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: Very Good. Shipped within 24 hours from our UK warehouse. Clean, undamaged book with no damage to pages and minimal wear to the cover. Spine still tight, in very good condition. Remember if you are not happy, you are covered by our 100% money back guarantee.
Da: Book Broker, Berlin, Germania
EUR 11,94
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Wie neu. 2002. 401 S. Alle Bücher & Medienartikel von Book Broker sind stets in gutem & sehr gutem gebrauchsfähigen Zustand. Dieser Artikel weist folgende Merkmale auf: Helle/saubere Seiten in fester Bindung. Sprache: Englisch Gewicht in Gramm: 813 Gebundene Ausgabe, Maße: 14.61 cm x 1.91 cm x 20.32 cm.
Lingua: Inglese
Editore: Berlin-Heidelberg-etc.pp., Springer Verlag, 2002
Da: Antiquariat Liber Antiqua, Krems an der Donau, Austria
EUR 15,00
Quantità: 1 disponibili
Aggiungi al carrellogebundene Ausgabe, Leinen. with 82 Figures, 376 pages abgegriffen, abgerieben, leicht verschmutzt, Kanten und Ecken bestossen, Seiten gebräunt, Stempel auf Titelblatt und Einbandinnenseite vorne, kein Schutzumschlag, guter Zustand, in Englisch Sprache: Englisch Ernst Schering Research Foundation Workshop 40.
EUR 11,99
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 408 | Sprache: Englisch | Produktart: Bücher | Since 1948, hydrocortisone (cortisol), the principal glucocorticoid (GC) of the human adrenal cortex has been successfully used at phar macological concentrations for the suppression of clinical manifesta tions of rheumatoid arthritis. Numerous compounds with GC activity have also been developed and used. Fifty years after their initial clinical use, GCs are still the most im portant and frequently prescribed class of anti-inflammatory drugs for various inflammatory disorders. They are administered either orally, parenterally (intravenous, intramuscular, intrathecal), or topically (cu taneous, intranasal, pulmonic, rectal). Despite the many beneficial ef fects of GCs, they also have their limitations and disadvantages that occur with varying prevalence on different organs and after different durations of therapy. These side-effects can range in severity from cos metic (e.g. telangiectasias, hypertrichosis) to seriously disabling (e.g. induction of glaucoma, diabetes, osteoporosis) or even life-threatening disorders (e.g. gastric haemorrhage). These adverse effects of GCs se riously handicap their successful use as anti-inflammatory agents. There is therefore a strong need for the development of substances with the anti-inflammatory potency of classical GCs but with reduced side-effects.
Lingua: Inglese
Editore: Berlin Heidelberg Spinger Verlag, 2002
ISBN 10: 3540432299 ISBN 13: 9783540432296
Da: CSG Onlinebuch GMBH, Darmstadt, Germania
EUR 24,61
Quantità: 1 disponibili
Aggiungi al carrelloGebunden. Condizione: Sehr gut. Gebraucht - Sehr gut Zustand: Sehr gut, Reihe: Ernst Schering Research Foundation Workshop , Band 40 XXI, 380 p. 82 illus., 10 in color. About this book The long-term use of glucocorticoids is associated with several deleterious effects. Attempts to separate the beneficial from the adverse effects of these compounds have met with varying degrees of difficulty. The discovery of distinct modes of action of the glucocorticoid receptor, the protein that mediates glucocorticoid action has opened up many possibilities for improving glucocorticoid therapy. This book provides an in-depth overview of the molecular actions of the glucocorticoid receptor and discusses the chances of an imminent identification of selective glucocorticoid agonists. Such componds should fulfill all the criteria of a glucocorticoid but should lack the sideeffects so far linked with classical glucocorticoids. Written for scientists and researchers in molecular medicine.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 167,19
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 140,10
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Recent Advances in Glucocorticoid Receptor Action | A. Cato (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2013 | Springer | EAN 9783662046623 | Verantwortliche Person für die EU: Springer Nature Customer Service Center GmbH, Tiergartenstr. 17, 69121 Heidelberg, productsafety[at]springernature[dot]com | Anbieter: preigu.
Condizione: New. pp. 408 Index.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2013
ISBN 10: 3662046628 ISBN 13: 9783662046623
Da: moluna, Greven, Germania
EUR 178,14
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. P.J. Barnes: Glucocorticoids and Asthma H.-D. Volk: Immunomonitoring of GC Therapy W.Sterry and K. Asadullah: Topical GC Therapy in DermatologyH.K. Vaeaenaenen and P.L. Haerkoenen: Bone Effects of GC Therapy U.Pleyer and Z. Sherif: Corticosteroids in Ophtalm.
Lingua: Inglese
Editore: Springer, Berlin, Springer, 2013
ISBN 10: 3662046628 ISBN 13: 9783662046623
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 168,73
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Since 1948, hydrocortisone (cortisol), the principal glucocorticoid (GC) of the human adrenal cortex has been successfully used at phar macological concentrations for the suppression of clinical manifesta tions of rheumatoid arthritis. Numerous compounds with GC activity have also been developed and used. Fifty years after their initial clinical use, GCs are still the most im portant and frequently prescribed class of anti-inflammatory drugs for various inflammatory disorders. They are administered either orally, parenterally (intravenous, intramuscular, intrathecal), or topically (cu taneous, intranasal, pulmonic, rectal). Despite the many beneficial ef fects of GCs, they also have their limitations and disadvantages that occur with varying prevalence on different organs and after different durations of therapy. These side-effects can range in severity from cos metic (e.g. telangiectasias, hypertrichosis) to seriously disabling (e.g. induction of glaucoma, diabetes, osteoporosis) or even life-threatening disorders (e.g. gastric haemorrhage). These adverse effects of GCs se riously handicap their successful use as anti-inflammatory agents. There is therefore a strong need for the development of substances with the anti-inflammatory potency of classical GCs but with reduced side-effects.
EUR 236,87
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 408 pages. 8.27x5.83x0.96 inches. In Stock.
Da: Basi6 International, Irving, TX, U.S.A.
EUR 127,57
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: Brand New. New. US edition. Print on demand title. Delivery takes 20-25 days.
Lingua: Inglese
Editore: Springer, J.B. Metzler Okt 2013, 2013
ISBN 10: 3662046628 ISBN 13: 9783662046623
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Since 1948, hydrocortisone (cortisol), the principal glucocorticoid (GC) of the human adrenal cortex has been successfully used at phar macological concentrations for the suppression of clinical manifesta tions of rheumatoid arthritis. Numerous compounds with GC activity have also been developed and used. Fifty years after their initial clinical use, GCs are still the most im portant and frequently prescribed class of anti-inflammatory drugs for various inflammatory disorders. They are administered either orally, parenterally (intravenous, intramuscular, intrathecal), or topically (cu taneous, intranasal, pulmonic, rectal). Despite the many beneficial ef fects of GCs, they also have their limitations and disadvantages that occur with varying prevalence on different organs and after different durations of therapy. These side-effects can range in severity from cos metic (e.g. telangiectasias, hypertrichosis) to seriously disabling (e.g. induction of glaucoma, diabetes, osteoporosis) or even life-threatening disorders (e.g. gastric haemorrhage). These adverse effects of GCs se riously handicap their successful use as anti-inflammatory agents. There is therefore a strong need for the development of substances with the anti-inflammatory potency of classical GCs but with reduced side-effects. 408 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 227,94
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 408.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 228,50
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 408.